The Asia Pacific Topical Corticosteroids Market is accounted to reach USD 837.11 million by 2024, from USD 506.28 million in 2016 growing at a CAGR of 6.5% in the forecast period 2017 to 2024

The major factors driving the growth of this market are increasing prevalence of chronic disease or condition, rise in aging population, growth in topical drug delivery, increasing research and development may hinder the growth of the market.

The key market players for Asia Pacific Topical Corticosteroids Market are listed below;

LEO Pharma
Glaxosmithkline Plc,
Pfizer Inc.

The market is further segmented into;
Molecule name
Brands
Purchase mode
Application
Medication type
Potency class
End user
Distribution channel
Geography

The Asia-Pacific topical corticosteroids market is segmented on the basis of molecule name, brands, purchase mode, application, medication type, potency class, end user, distribution channel. On the basis of molecule name, Asia-Pacific topical corticosteroids market is segmented into fludroxycortide, triamcinolone acetonide, fluocinolone acetonide, antiseptics, betamethasone, clobetasone propionate, clobetasone butyrate, halobetasone, mometasone, and others. In 2017, Fludroxycortide is expected to dominate the Asia-Pacific topical corticosteroids market with 26.2% market share and is expected to reach USD 229.42 million by 2024, growing at a CAGR of 7.2% in the forecast period 2017 to 2024. However, betamethasone is expected to grow at the highest CAGR of 7.5% in the forecast period, and is expected to reach USD 173.58 million in 2024 from USD 97.14 million in 2016.
On the basis of purchase mode, Asia-Pacific topical corticosteroids market is segmented into segmented into OTC-based and prescription-based. In 2017, prescription market segment is expected to dominate the Asia-Pacific topical corticosteroids market with 71.6% market share and is expected to reach USD 609.60 million by 2024, growing at the highest CAGR of 6.8% in the forecast period 2017 to 2024.
The Asia-Pacific topical corticosteroids market, on the basis of brands is segmented into betnovate, betnovate N, panderm plus, lobate, cosvate G, clop G, tenovate GN, lobate GM, ultiderm, flutivate, fexin, momate, candiderm, and others.
On the basis of application, Asia-Pacific topical corticosteroids market is segmented into acne, dermatitis, psoriasis, skin infection, hyperpigmentation, melasma and others. In 2017, psoriasis is expected to dominate the Asia-Pacific topical corticosteroids market with 42.5% market share and is expected to reach USD 370.88 million by 2024, growing at the highest CAGR of 7.1% in the forecast period 2017 to 2024.
The Asia-Pacific topical corticosteroids market is segmented based on medication type into ointments, creams, liquid & solutions, lotions, gel, oils, pastes, sprays, and others. In 2017, ointments is expected to dominate the Asia-Pacific topical corticosteroids market with 32.1% market share and is expected to reach USD 261.05 million by 2024, growing at a CAGR of 6.1% in the forecast period 2017 to 2024. However, lotions is expected to grow at the highest CAGR of 7.8% in the forecast period, and is expected to reach USD 93.99 million in 2024 from USD 51.55 million in 2016.
The Asia-Pacific topical corticosteroids market is segmented based on potency class into moderate, mild, ultra-high, and high. In 2017, moderate is expected to dominate the Asia-Pacific topical corticosteroids market with 41.4% market share and is expected to reach USD 359.89 million by 2024, growing at the highest CAGR of 7.1% in the forecast period 2017 to 2024.
The Asia-Pacific topical corticosteroids market is segmented based on end-user into three notable segments; hospital, dermatology clinics, homecare and others. In 2017, dermatology clinics is expected to dominate the Asia-Pacific topical corticosteroids market with 44.4% market share and is expected to reach USD 387.44 million by 2024, growing at the highest CAGR of 7.1% in the forecast period 2017 to 2024.
The Asia-Pacific topical corticosteroids market is segmented based on distribution channel into four notable segments; hospital pharmacies, pharmacy stores, online pharmacies and others. In 2017, pharmacy stores is expected to dominate the Asia-Pacific topical corticosteroids market with 44.6% market share and is expected to reach USD 390.11 million by 2024, growing at the highest CAGR of 7.2% in the forecast period 2017 to 2024..
Based on geography, the Asia Pacific Topical Corticosteroids Materials market is segmented into geographical regions, such as,
China,
Japan,
India,
South Korea,
Australia,
Thailand,
Malaysia,
Singapore,
Indonesia,
Philippines
Rest of Asia-Pacific

Covered in this report
The report covers the present scenario and the growth prospects of the Asia Pacific Topical Corticosteroids market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.